eScholarshipmetadata only
A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma
32 biomedical and clinical sciences (for-2020), 3202 clinical sciences (for-2020), 3211 oncology and carcinogenesis (for-2020), 3204 immunology (for-2020), vaccine related (rcdc), clinical trials and supportive activities (rcdc), clinical research (rcdc), orphan drug (rcdc)
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 492031
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.